InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Wolfe Peter. Officer active across 1 company, notably ZyVersa Therapeutics, Inc.. In total, 2 reports have been recorded. Activity tracked since 16 December 2022. The latest transaction was disclosed on 16 December 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations